Investors & Media

CEO Dr. Manos Perros discusses the current landscape of antibiotic development during the BIO CEO & Investor Conference Panel, "Removing Commercialization Barriers for New Antimicrobial Drugs"

Feb 11 - Feb 12, 2019

Supporting Materials